[
    [
        {
            "time": "",
            "original_text": "乐普医疗回应逾2亿收购亏损公司：博思美短期盈利仍存不确定性",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "收购",
                    "亏损公司",
                    "博思美",
                    "短期盈利",
                    "不确定性"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乐普医疗回应逾2亿收购亏损公司：博思美短期盈利仍存不确定性",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗：由于海外疫情及公司战略的调整，公司的生物可吸收支架系统暂未申请海外注册",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "海外疫情",
                    "战略调整",
                    "生物可吸收支架",
                    "海外注册"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乐普医疗：由于海外疫情及公司战略的调整，公司的生物可吸收支架系统暂未申请海外注册",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗：公司的PTA药物球囊、膝下PTA药物球囊、非顺应性PTA药物球囊导管正在临床阶段",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "PTA药物球囊",
                    "膝下PTA药物球囊",
                    "非顺应性PTA药物球囊导管",
                    "临床阶段"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：公司的PTA药物球囊、膝下PTA药物球囊、非顺应性PTA药物球囊导管正在临床阶段",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-04-28",
            "original_text": "乐普医疗：乐普生物已于2021年4月28日向联交所已经提交A1申请",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "乐普生物",
                    "联交所",
                    "A1申请",
                    "2021年4月28日"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：乐普生物已于2021年4月28日向联交所已经提交A1申请",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗：公司的监护设备其实已成熟运作20余年，主要面向海外市场，品质和服务都有很好的口碑",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "监护设备",
                    "海外市场",
                    "品质",
                    "服务",
                    "口碑"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：公司的监护设备其实已成熟运作20余年，主要面向海外市场，品质和服务都有很好的口碑",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]